On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance
β Scribed by Yan-Ping Hu; Sophie Jarillon; Catherine Dubernet; Patrick Couvreur; J. Robert
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 410 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Development of resistance to one type of lipophilic chemotherapeutic drug often leads to resistance to other, structurally unrelated, lipophilic drugs. This suggests that non-toxic lipophilic agents may interfere with and reverse drug resistance by saturating the pathway through which multidrugresis
A variety of seven nonionic, one amphoteric and, one anionic surfactant that are applied or investigated as surfactants in drug formulation, were analyzed for their capacity to modulate carrier-mediated transport by efflux pumps. Two cell lines, murine monocytic leukemia cells overexpressing P-glyco
## Abstract Multidrug resistance protein 1 (MRP1) belongs to the ATPβbinding cassette (ABC) transporter family. It is able to transport a broad range of anticancer drugs through cellular membranes, thus limiting their antiproliferative action. Since its discovery in 1992, MRP1 has been the most stu